Orlando Health, Inc. TRIO — Orlando, Florida

Orlando Health, Inc. TRIO is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Orlando Health, Inc. TRIO has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, HER2 Positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Seagen Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Orlando Health, Inc. TRIO?

Orlando Health, Inc. TRIO has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Orlando Health, Inc. TRIO conducted?

Orlando Health, Inc. TRIO has 2 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, HER2 Positive Breast Cancer.

Is Orlando Health, Inc. TRIO accredited by Crixeo Health?

Orlando Health, Inc. TRIO has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Orlando Health, Inc. TRIO?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.